Raltegravir-based Antiretroviral Therapy for Resistant HIV-1 Infection

NCT01844310 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

AIDS/HIV PROBLEM

Interventions

DRUG: RAL+TDF+LPV/r
DRUG: 3TC+TDF+LPV/r

Sponsor

Peking Union Medical College